4-(4-{[N-cyclopropyl-1-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)formamido]methyl}benzamido)benzoic acid
Structure Info
- Chemspace ID
- CSSB20621630380 (In-Stock Building Blocks)
- CAS
- 2929306-91-0
- MFCD
- MFCD35782740
- IUPAC Name
- 4-(4-{[N-cyclopropyl-1-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)formamido]methyl}benzamido)benzoic acid
- Mol formula
- C27H23N3O6
- Mol weight
- 485 Da
- Catalog Number(s)
- AR0GTVUQ, BBLS20621630380, EN300-52134513, ST0GTWMI, bbls20621630380
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.99
- Heavy atoms count
- 36
- Rotatable bond count
- 7
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.185
- Polar surface area (Å)
- 125
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 3
![Chemical structure of 4-(4-{[N-cyclopropyl-1-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)formamido]methyl}benzamido)benzoic acid (C27H23N3O6) - CSSB20621630380](/st/structure/200/afe5ce950f7e9cd2bd12e5eafba5706c/OC%2528%253DO%2529C1%253DCC%253DC%2528NC%2528%253DO%2529C2%253DCC%253DC%2528CN%2528C3CC3%2529C%2528%253DO%2529C3%253DCC%253DC4NC%2528%253DO%2529COC4%253DC3%2529C%253DC2%2529C%253DC1.png "C27H23N3O6")
- Zoom the structure
- CSSB20621630380
Items Overall 21 items from 4 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 252.18 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 342.17 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 511.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 602.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 730.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 344.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 515.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 735.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 1,158.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 1,485.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 2,912.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 252.18 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 342.17 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 511.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 602.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 730.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 50 mg | 452.10 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 100 mg | 650.10 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 250 mg | 904.20 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 500 mg | 1,393.70 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 1 g | 1,773.20 | |
Description: 4-(4-{[N-cyclopropyl-1-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)formamido]methyl}benzamido)benzoic acid; CAS: 2929306-91-0 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 4-{[N-cyclopropyl-1-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)formamido]methyl}benzoic acid - CSSB01036757230](/st/structure/200/274e228049fcc1b8d1514fd09fbb0466/OC%2528%253DO%2529C1%253DCC%253DC%2528CN%2528C2CC2%2529C%2528%253DO%2529C2%253DCC%253DC3NC%2528%253DO%2529COC3%253DC2%2529C%253DC1.png)
![Chemical structure of N-{[4-({4-[(6-aminohexyl)carbamoyl]phenyl}carbamoyl)phenyl]methyl}-N-cyclopropyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-carboxamide - CSSB20591796628](/st/structure/200/5b99eae9a3a2bd32a6c14f5a09dd6b03/NCCCCCCNC%2528%253DO%2529C1%253DCC%253DC%2528NC%2528%253DO%2529C2%253DCC%253DC%2528CN%2528C3CC3%2529C%2528%253DO%2529C3%253DCC%253DC4NC%2528%253DO%2529COC4%253DC3%2529C%253DC2%2529C%253DC1.png)
![Chemical structure of N-{[4-({4-[(6-aminohexyl)carbamoyl]phenyl}carbamoyl)phenyl]methyl}-N-cyclopropyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-carboxamide; trifluoroacetic acid - CSSB14880533436](/st/structure/200/b8d75bce1f4c90f669c84b0ab270a67b/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCCNC%2528%253DO%2529c1ccc%2528NC%2528%253DO%2529c2ccc%2528CN%2528C3CC3%2529C%2528%253DO%2529c3ccc4NC%2528%253DO%2529COc4c3%2529cc2%2529cc1.png)
![Chemical structure of N-cyclopropyl-3-oxo-N-({4-[(pyrimidin-4-yl)carbamoyl]phenyl}methyl)-3,4-dihydro-2H-1,4-benzoxazine-7-carboxamide - CSSB06446548072](/st/structure/200/d9920eae12511b80c1b810239fd1e13a/O%253DC%2528Nc1ccncn1%2529c1ccc%2528CN%2528C2CC2%2529C%2528%253DO%2529c2ccc3NC%2528%253DO%2529COc3c2%2529cc1.png)
![Chemical structure of N-[(4-{[2-(6-aminohexanoyl)-1,2,3,4-tetrahydroisoquinolin-6-yl]carbamoyl}phenyl)methyl]-N-cyclopropyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-carboxamide; trifluoroacetic acid - CSSB20591796608](/st/structure/200/c81f8f14a0f21e56fceb5dc15739a9a0/OC%2528%253DO%2529C%2528F%2529%2528F%2529F.NCCCCCC%2528%253DO%2529N1CCC2%253DCC%2528NC%2528%253DO%2529C3%253DCC%253DC%2528CN%2528C4CC4%2529C%2528%253DO%2529C4%253DCC%253DC5NC%2528%253DO%2529COC5%253DC4%2529C%253DC3%2529%253DCC%253DC2C1.png)
![Chemical structure of 3-oxo-N-(propan-2-yl)-N-({4-[(pyrimidin-4-yl)carbamoyl]phenyl}methyl)-3,4-dihydro-2H-1,4-benzoxazine-7-carboxamide - CSSB06256033944](/st/structure/200/33f2e46f60cafd86ebca6be7cd9a20d4/CC%2528C%2529N%2528Cc1ccc%2528cc1%2529C%2528%253DO%2529Nc1ccncn1%2529C%2528%253DO%2529c1ccc2NC%2528%253DO%2529COc2c1.png)
